Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Capricor Therapeutics, Inc. (CAPR) had Return on Equity of -19.11% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-24.39M |
|
-- |
|
-- |
|
$24.98M |
|
$-24.98M |
|
$0.59M |
|
$-24.39M |
|
$-24.24M |
|
$-24.39M |
|
$-24.39M |
|
$-24.39M |
|
$-24.24M |
|
$-24.98M |
|
$-24.58M |
|
45.64M |
|
45.64M |
|
$-0.53 |
|
$-0.53 |
|
| Balance Sheet Financials | |
$146.25M |
|
$6.13M |
|
$7.51M |
|
$153.77M |
|
$22.34M |
|
-- |
|
$3.78M |
|
$26.12M |
|
$127.65M |
|
$127.65M |
|
$127.65M |
|
45.68M |
|
| Cash Flow Statement Financials | |
$-6.43M |
|
$23.89M |
|
$0.05M |
|
$11.29M |
|
$28.79M |
|
$17.51M |
|
$5.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.55 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.57M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-19.11% |
-19.11% |
|
-15.86% |
|
-19.11% |
|
$2.79 |
|
$-0.17 |
|
$-0.14 |
|